Roche’s Strategic Pivot Gains Momentum from Immunology and Capital Restructuring
Roche reports strong Phase III lupus data for Gazyva and finalizes share conversion. The company also increased its…
UBS Bolsters Leadership with High-Profile Appointments Amid Restructuring
UBS nominates ex-BIS head Agustín Carstens and former Apple CFO Luca Maestri to its board, targeting regulatory and…
Nestlé’s Restructuring Drive Gains Momentum with Strategic Overhaul
Nestlé accelerates its corporate overhaul, focusing on coffee, pet care, nutrition, and everyday foods while cutting 16,000 jobs…
Weil Advises Glencore on the Acquisition of Li-Cycle in CCAA and Chapter 15 Proceedings
Weil advised Glencore Canada Corporation (a subsidiary of Glencore plc) and certain of its affiliates on its acquisition…
Fierce Biotech Layoff Tracker 2025
We hoped industry layoffs would relent in 2024. That’s not what happened. Overall, biopharma layoffs rose 3% last…
Nestlé is laying off over 16,000 employees under its new CEO—and says a key motivator is ‘automation’
Nestlé will lay off 16,000 employees worldwide as recently-appointed CEO Philipp Navratil looks to turn around the world’s…